What is Palvella Therapeutics's return on equity?

Palvella Therapeutics (PVLA) reported return on equity of -34.2% in Q1 2026.

What is the long-term trend for Palvella Therapeutics's return on equity?

Over 2 years (2020 to 2025), Palvella Therapeutics's return on equity has grown at a 0.9% compound annual growth rate (CAGR), from -90.4% to -92.1%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Palvella Therapeutics PVLA Return on equity

Return on equity at other companies

Relay Therapeutics, Inc.RLAY

-40%-4.3pp

Viridian Therapeutics, Inc.VRDN

-58.1%+7.9pp

ANI PharmaceuticalsANIP

18.8%+15.6pp

PrecigenPGEN

-843.6%-1,103pp

Arcutis Biotherapeutics, Inc.ARQT

-28.2%-13.0pp

Kodiak Sciences IncKOD

-208.8%+2,306pp

Other financials

Income statement

See full

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

See full

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Total assets$263.8M+232%

Cash flow

See full

Operating cash flow-$10.9M-60.5%

CapEx--100%

Free cash flow-$2.7M+72.0%

Valuation

See full

Market cap$1.7B+468%

Enterprise value$1.5B—

P/S41.6×—

Profitability

See full

Operating margin-183.2%-13.5pp

Net margin71.7%+40.4pp

FCF margin-99.8%-34.2pp

Returns & leverage

See full

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Calculated from Palvella Therapeutics’s reported figures.

net income/total stockholders equity=-34.2%

Based on trailing twelve months.

The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Palvella Therapeutics's return on equity?: Palvella Therapeutics (PVLA) reported return on equity of -34.2% in Q1 2026.
What is the long-term trend for Palvella Therapeutics's return on equity?: Over 2 years (2020 to 2025), Palvella Therapeutics's return on equity has grown at a 0.9% compound annual growth rate (CAGR), from -90.4% to -92.1%.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.